Rationale and study design of a trial to assess rTMS add-on value for the amelioration of negative symptoms of schizophrenia (RADOVAN)
Autor: | Hebel, T., Langguth, B., Schecklmann, M., Schoisswohl, S., Staudinger, S., Schiller, A., Ustohal, L., Sverak, T., Horky, M., Kasparek, T., Skront, T., Hyza, M., Poeppl, T.B., Riester, M.L., Schwemmer, L., Zimmermann, S., Sakreida, K. |
---|---|
Zdroj: | In Contemporary Clinical Trials Communications April 2022 26 |
Databáze: | ScienceDirect |
Externí odkaz: |